Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patient is \>18 years of age~* The patient has provided written informed consent and understands the explanation of the protocol.~* The patient is scheduled to have a unilateral renal transplant with a flank incision~Exclusion Criteria:~* Patients aged \<18.~* Patients with a known allergy to amide local anesthetics or para-aminobenzoic acid.~* Patients who are unable to understand the verbal analog pain scale.~* Patients who decline participation.~* Patients with a midline abdominal incision.~* Combined transplants, ie. Kidney-pancreas

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Fentanyl IV PCA and placebo TAP catheter (Type: PLACEBO_COMPARATOR): Patients will receive Fentanyl IV PCA and placebo TAP catheter.
- TAP catheter with continuous infusion of Ropivicaine (Type: ACTIVE_COMPARATOR): Patients will receive TAP catheter with continuous infusion of Ropivicaine for up to 48 hours after surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).